Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mallinckrodt PLC (MNK), Pfizer Inc. (PFE): Healthcor Management’s Top 5 Health Stocks

Page 1 of 2

Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014. There has been a great deal of turnover among Healthcor’s top five picks, as only one pick from the previous quarter remains among its top choices. Meanwhile, three newly opened positions during the fourth quarter crack the top five.

Arthur B Cohen and Joseph Healey

As its name would suggest, Healthcor Management is a healthcare-focused hedge fund that was founded in 2005 by Cohen and Healey. The former is a “Tiger Cub”, who managed the healthcare investments of Julian Robertson’s Tiger Management from 1995 to 2000, while working as its managing director. Cohen later moved to SAC Capital Partners (now the family office Point72 Asset Management), working there until 2005. Healthcor was 93% invested in the healthcare sector at the end of 2014, with an equity portfolio valued at $1.79 billion.

One of those falling from the top five is Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), which was previously Healthcor’s top pick, and still ranked fourth at the end of the third quarter, even after Healthcor slashed over 25% of its position near the end of the third quarter. In the fourth quarter, Healthcor completely closed the position.

Mallinckrodt PLC (NYSE:MNK) is the one stock that remains in Healthcor’s top five, and not only that, it remains its top pick for the second straight quarter, though it did trim the position by 27% during the fourth quarter, down to 1.33 million shares. Mallinckrodt was one of Healthcor’s best picks in 2014, as it opened a position on the specialty pharmaceuticals company during the first quarter. Mallinckrodt soared 92.7% for the year, and is up another 19.77% year-to-date. All told, shares are up 172.67% since the company’s IPO in the summer of 2013.

John Paulson’s Paulson & Co. has been one of the biggest beneficiaries of that tremendous growth, having held 5.64 million shares at the end of the third quarter of 2013, which are now worth 150% what they were at the time, a windfall of more than $400 million. Paulson & Co. is still the largest shareholder among funds we track with 9.01 million shares.

Gilead Sciences, Inc. (NASDAQ:GILD) is Healthcor’s top new pick, as it opened a position on the biotech company during the fourth quarter consisting of 1.25 million shares. Best known for its Hepatitis C drug Sovaldi, which had $10.3 billion is sales in and 2014, and the HIV treatment Stribild, Gilead is in the midst of a strong three year run, up 350% during that time. Unsurprisingly, it’s been one of the top healthcare stocks among the funds we track, as well as a favorite stock among billionaires. Overall fund ownership has increased to 13.2% from 11.9%, and Ken Griffin and Steve Cohen are among the billionaires with stakes in Gilead.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!